BioSpace News Archive

Press Releases

Eureka Therapeutics Appoints Dr. Reginald Seeto and William S. Solari III to Board of Directors

August 13, 2025
·
1 min read
Press Releases

Jocasta Neuroscience Lands $35 Million Series A to Advance Longevity Protein Program for Managing Cognitive Impairment

August 13, 2025
·
3 min read
Press Releases

Myra Vision Secures FDA Approval to Initiate US IDE Study in Glaucoma

August 13, 2025
·
3 min read
Press Releases

Mabwell Announces First Patient Dosed in the US Clinical Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated with ADCs

August 13, 2025
·
5 min read
Press Releases

Former Pfizer Chief Scientific Officer joins MC Sciences as Independent Chairman

August 13, 2025
·
5 min read
Press Releases

Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates

August 13, 2025
·
3 min read
Press Releases

Artios Pharma Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development

August 13, 2025
·
5 min read
Press Releases

Scilex Holding Company (Nasdaq: SCLX) Announces Effectiveness of Registration Statement on Form S-4 for the Proposed Business Combination of Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, Inc., a Majority-Owned Subsidiary of Scilex

August 13, 2025
·
12 min read
Press Releases

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease

August 13, 2025
·
5 min read
Press Releases

Neuronascent Announces Progress for Lead Candidate NNI-362: Publication of Phase 1a Clinical Trial Results and FDA Grants Waiver of Fee for Canine Cognitive Disorder 2025 Submissions

August 13, 2025
·
3 min read